7 results match your criteria: "Sir Peter MacCallum Department of Oncology University of Melbourne Parkville VIC Australia.[Affiliation]"
Objectives: Haematopoietic stem cell transplant (HCT) is a cellular therapy that, whilst curative for a child's underlying disease, carries significant risk of mortality, including because of pulmonary complications. The aims of this study were to describe the burden of pulmonary complications post-HCT in a cohort of Australian children and identify risk factors for the development of these complications.
Methods: Patients were identified from the HCT databases at two paediatric transplant centres in Australia.
It is important to identify a retained fecalith and remove that infective nidus to decrease the morbidity in patients undergoing laparoscopic appendectomy for perforated appendicitis.
View Article and Find Full Text PDFContext: Ductal adenocarcinoma (DAC) is relatively rare, but is nonetheless the second most common subtype of prostate cancer. First described in 1967, opinion is still divided regarding its biology, prognosis, and outcome.
Objectives: To systematically interrogate the literature to clarify the epidemiology, diagnosis, management, progression, and survival statistics of DAC.
Clin Transl Immunology
September 2020
Sir Peter MacCallum Department of Oncology University of Melbourne Parkville VIC Australia.
Objective: To describe the technical aspects and outcomes of robotic-assisted radical prostatectomy (RARP) following abandoned open radical prostatectomy (ORP).
Patients And Methods: A retrospective review was performed of patients who underwent RARP following abandonment of ORP between 2016 and 2020. RARP was undertaken by two highly experienced robotic surgeons.
Objectives: To determine the rate of morbidity and assess the oncological outcomes for the subinguinal orchidectomy technique.
Background: Radical inguinal orchiectomy is the definitive management for a testicular mass suspicious for malignancy. The standard approach involves the division of the spermatic cord at the internal inguinal ring.
Objectives: Adoptive transfer of chimeric antigen receptor (CAR)-modified T cells is a form of cancer immunotherapy that has achieved remarkable efficacy in patients with some haematological cancers. However, challenges remain in CAR T-cell treatment of solid tumours because of tumour-mediated immunosuppression.
Methods: We have demonstrated that CAR T-cell stimulation through T-cell receptors (TCRs) can generate durable responses against solid tumours in a variety of murine models.